Correlation Between Sherwin Williams and Endocan Corp

Can any of the company-specific risk be diversified away by investing in both Sherwin Williams and Endocan Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sherwin Williams and Endocan Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sherwin Williams Co and Endocan Corp, you can compare the effects of market volatilities on Sherwin Williams and Endocan Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sherwin Williams with a short position of Endocan Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sherwin Williams and Endocan Corp.

Diversification Opportunities for Sherwin Williams and Endocan Corp

0.38

Correlation Coefficient

Sherwin Williams  Endocan Corp

Weak diversification

The 3 months correlation between Sherwin and Endocan is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Sherwin Williams Co and Endocan Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Endocan Corp and Sherwin Williams is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sherwin Williams Co are associated (or correlated) with Endocan Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Endocan Corp has no effect on the direction of Sherwin Williams i.e., Sherwin Williams and Endocan Corp go up and down completely randomly.

Pair Corralation between Sherwin Williams and Endocan Corp

Considering the 90-day investment horizon Sherwin Williams is expected to generate 887.57 times less return on investment than Endocan Corp. But when comparing it to its historical volatility, Sherwin Williams Co is 98.99 times less risky than Endocan Corp. It trades about 0.01 of its potential returns per unit of risk. Endocan Corp is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  0.01  in Endocan Corp on December 28, 2024 and sell it today you would earn a total of  0.00  from holding Endocan Corp or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.36%
Values	Daily Returns

Sherwin Williams Co  vs.  Endocan Corp

Sherwin Williams

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Sherwin Williams Co are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable technical indicators, Sherwin Williams is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Endocan Corp

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Endocan Corp are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile fundamental indicators, Endocan Corp displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sherwin Williams and Endocan Corp

The main advantage of trading using opposite Sherwin Williams and Endocan Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sherwin Williams position performs unexpectedly, Endocan Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endocan Corp will offset losses from the drop in Endocan Corp's long position.

The idea behind Sherwin Williams Co and Endocan Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.